Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 10 June 2021 to Questions 11719, 11720, 11721 and 11722 on Pancreatic Cancer: Medical Treatments, in what format information on the proportion of pancreatic cancer patients in England prescribed with pancreatic enzyme replacement therapy (PERT) is available, and if he will publish what information his Department holds on the proportion of pancreatic cancer patients in England prescribed with that treatment.

The Department has no plans to do so.

The following table shows the number of items that were prescribed for pancreatic enzyme replacement therapy medicines and dispensed in the community in England in each year from 2015 to 2019. No data is captured on the prescription form about the clinical indication for which a prescription is intended.